(Q41879833)

13 October 2017

title

CA-125 serum concentrations during the menstrual cycle (English)

1 reference

13 October 2017

W Jäger

1

1 reference

13 October 2017

C Meier

2

1 reference

13 October 2017

L Wildt

3

1 reference

13 October 2017

W Sauerbrei

4

1 reference

13 October 2017

N Lang

5

1 reference

13 October 2017

language of work or name

English

0 references

publication date

1 August 1988

1 reference

13 October 2017

published in

Fertility and Sterility

1 reference

13 October 2017

volume

50

1 reference

13 October 2017

issue

2

1 reference

13 October 2017

page(s)

223-227

1 reference

Use of the CA 125 antigen in diagnosis and monitoring of ovarian carcinoma

13 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960063-8

Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960063-8

Elevated serum concentrations of CA-125 in patients with advanced endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960063-8

Elevated levels of CA-125 in serum of patients suffering from ovarian hyperstimulation syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960063-8

Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the inadequate luteal phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960063-8

7 January 2021

The Short Luteal Phase12

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960063-8

Immunoelectronmicroscopic demonstration of surface tumor antigen Ca 125

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960063-8

Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960063-8

Ca 125 and Ca 19-9: two cancer-associated sialylsaccharide antigens on a mucus glycoprotein from human milk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960063-8

Elevation of CA 125 in patients with benign and malignant ascites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960063-8

CA 125 antigen in human amniotic fluid and fetal membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960063-8

Serum levels of CA-125 in patients with endometriosis: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960063-8

Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients' sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960063-8

The tumor marker CA 125 is a common constituent of normal cervical mucus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960063-8

Gonadotropin-Binding Sites in the Rhesus Monkey Ovary: Role of the Vasculature in the Selective Distribution of Human Chorionic Gonadotropin to the Preovulatory Follicle*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960063-8

Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960063-8

10.1016/S0015-0282(16)60063-8

7 January 2021

Identifiers

DOI

0 references

1 reference